ProKidney Corp [NASDAQ: PROK] traded at a high on Thursday, posting a 13.10 gain after which it closed the day’ session at $1.64.
The results of the trading session contributed to over 2876710 shares changing hands. Over the past one week, the price volatility of ProKidney Corp stands at 8.40% while the volatility over the past one month is 8.67%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for PROK stock reached $101.06 million, with 59.88 million shares outstanding and 43.22 million shares in the current float. Compared to the average trading volume of 487.90K shares, PROK reached a trading volume of 2876710 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about ProKidney Corp [PROK]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PROK shares is $3.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PROK stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for ProKidney Corp shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on March 07, 2024. The new note on the price target was released on January 02, 2024, representing the official price target for ProKidney Corp stock. Previously, the target price had yet another raise to $16, while BTIG Research analysts kept a Buy rating on PROK stock.
How has PROK stock performed recently?
ProKidney Corp [PROK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.89. With this latest performance, PROK shares gained by 9.33% in over the last four-week period, additionally sinking by -63.64% over the last 6 months – not to mention a drop of -85.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PROK stock in for the last two-week period is set at 58.35, with the RSI for the last a single of trading hit 62.79, and the three-weeks RSI is set at 55.31 for ProKidney Corp [PROK]. The present Moving Average for the last 50 days of trading for this stock 1.4647, while it was recorded at 1.5080 for the last single week of trading, and 4.4139 for the last 200 days.
ProKidney Corp [PROK]: Deeper insight into the fundamentals
ProKidney Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 14.94 and a Current Ratio set at 14.94.
Insider trade positions for ProKidney Corp [PROK]
The top three institutional holders of PROK stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in PROK stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in PROK stock with ownership which is approximately 5.8386%.
